Global Type 1 Diabetes Drugs Market Growth 2022-2028

January 2022 | 108 pages | ID: GEC615A11652EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Type 1 Diabetes Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Type 1 Diabetes Drugs market size is USD million in 2022 from USD 10620 million in 2021, with a change of % between 2021 and 2022. The global Type 1 Diabetes Drugs market size will reach USD 15390 million in 2028, growing at a CAGR of 5.4% over the analysis period.

The United States Type 1 Diabetes Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Type 1 Diabetes Drugs market, reaching US$ million by the year 2028. As for the Europe Type 1 Diabetes Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Type 1 Diabetes Drugs players cover Novo Nordisk, Sanofi, Eli Lily, and Adocia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Type 1 Diabetes Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

• Insulins
• Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

• Drugstore
• Hospital
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

• Novo Nordisk
• Sanofi
• Eli Lily
• Adocia
• Astellas Pharma
• AstraZeneca
• BHV Pharma
• Biodel
• Boehringer Ingelheim
• Diamyd Therapeutics AB

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Type 1 Diabetes Drugs Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Type 1 Diabetes Drugs by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Type 1 Diabetes Drugs by Country/Region, 2017, 2022 & 2028
2.2 Type 1 Diabetes Drugs Segment by Type
  2.2.1 Insulins
  2.2.2 Others
2.3 Type 1 Diabetes Drugs Sales by Type
  2.3.1 Global Type 1 Diabetes Drugs Sales Market Share by Type (2017-2022)
  2.3.2 Global Type 1 Diabetes Drugs Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Type 1 Diabetes Drugs Sale Price by Type (2017-2022)
2.4 Type 1 Diabetes Drugs Segment by Application
  2.4.1 Drugstore
  2.4.2 Hospital
  2.4.3 Others
2.5 Type 1 Diabetes Drugs Sales by Application
  2.5.1 Global Type 1 Diabetes Drugs Sale Market Share by Application (2017-2022)
  2.5.2 Global Type 1 Diabetes Drugs Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Type 1 Diabetes Drugs Sale Price by Application (2017-2022)

3 GLOBAL TYPE 1 DIABETES DRUGS BY COMPANY

3.1 Global Type 1 Diabetes Drugs Breakdown Data by Company
  3.1.1 Global Type 1 Diabetes Drugs Annual Sales by Company (2020-2022)
  3.1.2 Global Type 1 Diabetes Drugs Sales Market Share by Company (2020-2022)
3.2 Global Type 1 Diabetes Drugs Annual Revenue by Company (2020-2022)
  3.2.1 Global Type 1 Diabetes Drugs Revenue by Company (2020-2022)
  3.2.2 Global Type 1 Diabetes Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Type 1 Diabetes Drugs Sale Price by Company
3.4 Key Manufacturers Type 1 Diabetes Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Type 1 Diabetes Drugs Product Location Distribution
  3.4.2 Players Type 1 Diabetes Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR TYPE 1 DIABETES DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Type 1 Diabetes Drugs Market Size by Geographic Region (2017-2022)
  4.1.1 Global Type 1 Diabetes Drugs Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Type 1 Diabetes Drugs Annual Revenue by Geographic Region
4.2 World Historic Type 1 Diabetes Drugs Market Size by Country/Region (2017-2022)
  4.2.1 Global Type 1 Diabetes Drugs Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Type 1 Diabetes Drugs Annual Revenue by Country/Region
4.3 Americas Type 1 Diabetes Drugs Sales Growth
4.4 APAC Type 1 Diabetes Drugs Sales Growth
4.5 Europe Type 1 Diabetes Drugs Sales Growth
4.6 Middle East & Africa Type 1 Diabetes Drugs Sales Growth

5 AMERICAS

5.1 Americas Type 1 Diabetes Drugs Sales by Country
  5.1.1 Americas Type 1 Diabetes Drugs Sales by Country (2017-2022)
  5.1.2 Americas Type 1 Diabetes Drugs Revenue by Country (2017-2022)
5.2 Americas Type 1 Diabetes Drugs Sales by Type
5.3 Americas Type 1 Diabetes Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Type 1 Diabetes Drugs Sales by Region
  6.1.1 APAC Type 1 Diabetes Drugs Sales by Region (2017-2022)
  6.1.2 APAC Type 1 Diabetes Drugs Revenue by Region (2017-2022)
6.2 APAC Type 1 Diabetes Drugs Sales by Type
6.3 APAC Type 1 Diabetes Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Type 1 Diabetes Drugs by Country
  7.1.1 Europe Type 1 Diabetes Drugs Sales by Country (2017-2022)
  7.1.2 Europe Type 1 Diabetes Drugs Revenue by Country (2017-2022)
7.2 Europe Type 1 Diabetes Drugs Sales by Type
7.3 Europe Type 1 Diabetes Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Type 1 Diabetes Drugs by Country
  8.1.1 Middle East & Africa Type 1 Diabetes Drugs Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Type 1 Diabetes Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Type 1 Diabetes Drugs Sales by Type
8.3 Middle East & Africa Type 1 Diabetes Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Type 1 Diabetes Drugs
10.3 Manufacturing Process Analysis of Type 1 Diabetes Drugs
10.4 Industry Chain Structure of Type 1 Diabetes Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Type 1 Diabetes Drugs Distributors
11.3 Type 1 Diabetes Drugs Customer

12 WORLD FORECAST REVIEW FOR TYPE 1 DIABETES DRUGS BY GEOGRAPHIC REGION

12.1 Global Type 1 Diabetes Drugs Market Size Forecast by Region
  12.1.1 Global Type 1 Diabetes Drugs Forecast by Region (2023-2028)
  12.1.2 Global Type 1 Diabetes Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Type 1 Diabetes Drugs Forecast by Type
12.7 Global Type 1 Diabetes Drugs Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk Type 1 Diabetes Drugs Product Offered
  13.1.3 Novo Nordisk Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
  13.2.1 Sanofi Company Information
  13.2.2 Sanofi Type 1 Diabetes Drugs Product Offered
  13.2.3 Sanofi Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Sanofi Main Business Overview
  13.2.5 Sanofi Latest Developments
13.3 Eli Lily
  13.3.1 Eli Lily Company Information
  13.3.2 Eli Lily Type 1 Diabetes Drugs Product Offered
  13.3.3 Eli Lily Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Eli Lily Main Business Overview
  13.3.5 Eli Lily Latest Developments
13.4 Adocia
  13.4.1 Adocia Company Information
  13.4.2 Adocia Type 1 Diabetes Drugs Product Offered
  13.4.3 Adocia Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Adocia Main Business Overview
  13.4.5 Adocia Latest Developments
13.5 Astellas Pharma
  13.5.1 Astellas Pharma Company Information
  13.5.2 Astellas Pharma Type 1 Diabetes Drugs Product Offered
  13.5.3 Astellas Pharma Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Astellas Pharma Main Business Overview
  13.5.5 Astellas Pharma Latest Developments
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Information
  13.6.2 AstraZeneca Type 1 Diabetes Drugs Product Offered
  13.6.3 AstraZeneca Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 AstraZeneca Main Business Overview
  13.6.5 AstraZeneca Latest Developments
13.7 BHV Pharma
  13.7.1 BHV Pharma Company Information
  13.7.2 BHV Pharma Type 1 Diabetes Drugs Product Offered
  13.7.3 BHV Pharma Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 BHV Pharma Main Business Overview
  13.7.5 BHV Pharma Latest Developments
13.8 Biodel
  13.8.1 Biodel Company Information
  13.8.2 Biodel Type 1 Diabetes Drugs Product Offered
  13.8.3 Biodel Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Biodel Main Business Overview
  13.8.5 Biodel Latest Developments
13.9 Boehringer Ingelheim
  13.9.1 Boehringer Ingelheim Company Information
  13.9.2 Boehringer Ingelheim Type 1 Diabetes Drugs Product Offered
  13.9.3 Boehringer Ingelheim Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Boehringer Ingelheim Main Business Overview
  13.9.5 Boehringer Ingelheim Latest Developments
13.10 Diamyd Therapeutics AB
  13.10.1 Diamyd Therapeutics AB Company Information
  13.10.2 Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Offered
  13.10.3 Diamyd Therapeutics AB Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Diamyd Therapeutics AB Main Business Overview
  13.10.5 Diamyd Therapeutics AB Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Type 1 Diabetes Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Type 1 Diabetes Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Insulins
Table 4. Major Players of Others
Table 5. Global Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Type 1 Diabetes Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Type 1 Diabetes Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Type 1 Diabetes Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Type 1 Diabetes Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Type 1 Diabetes Drugs Revenue by Application (2017-2022)
Table 13. Global Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Type 1 Diabetes Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Type 1 Diabetes Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Type 1 Diabetes Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Type 1 Diabetes Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Type 1 Diabetes Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Type 1 Diabetes Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Type 1 Diabetes Drugs Producing Area Distribution and Sales Area
Table 21. Players Type 1 Diabetes Drugs Products Offered
Table 22. Type 1 Diabetes Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Type 1 Diabetes Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Type 1 Diabetes Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Type 1 Diabetes Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Type 1 Diabetes Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Type 1 Diabetes Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Type 1 Diabetes Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Type 1 Diabetes Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Type 1 Diabetes Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Type 1 Diabetes Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Type 1 Diabetes Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Type 1 Diabetes Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Type 1 Diabetes Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Type 1 Diabetes Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Type 1 Diabetes Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Type 1 Diabetes Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Type 1 Diabetes Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Type 1 Diabetes Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Type 1 Diabetes Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Type 1 Diabetes Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Type 1 Diabetes Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Type 1 Diabetes Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Type 1 Diabetes Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Type 1 Diabetes Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Type 1 Diabetes Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Type 1 Diabetes Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Type 1 Diabetes Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Type 1 Diabetes Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Type 1 Diabetes Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Type 1 Diabetes Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Type 1 Diabetes Drugs
Table 66. Key Market Challenges & Risks of Type 1 Diabetes Drugs
Table 67. Key Industry Trends of Type 1 Diabetes Drugs
Table 68. Type 1 Diabetes Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Type 1 Diabetes Drugs Distributors List
Table 71. Type 1 Diabetes Drugs Customer List
Table 72. Global Type 1 Diabetes Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Type 1 Diabetes Drugs Sales Market Forecast by Region
Table 74. Global Type 1 Diabetes Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Type 1 Diabetes Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Type 1 Diabetes Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Type 1 Diabetes Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Type 1 Diabetes Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Type 1 Diabetes Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Type 1 Diabetes Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Type 1 Diabetes Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Type 1 Diabetes Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Type 1 Diabetes Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Type 1 Diabetes Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Type 1 Diabetes Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Type 1 Diabetes Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Type 1 Diabetes Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Type 1 Diabetes Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Type 1 Diabetes Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Type 1 Diabetes Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Type 1 Diabetes Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Type 1 Diabetes Drugs Product Offered
Table 94. Novo Nordisk Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
Table 97. Sanofi Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Type 1 Diabetes Drugs Product Offered
Table 99. Sanofi Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Main Business
Table 101. Sanofi Latest Developments
Table 102. Eli Lily Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Eli Lily Type 1 Diabetes Drugs Product Offered
Table 104. Eli Lily Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Eli Lily Main Business
Table 106. Eli Lily Latest Developments
Table 107. Adocia Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Adocia Type 1 Diabetes Drugs Product Offered
Table 109. Adocia Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Adocia Main Business
Table 111. Adocia Latest Developments
Table 112. Astellas Pharma Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Astellas Pharma Type 1 Diabetes Drugs Product Offered
Table 114. Astellas Pharma Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Astellas Pharma Main Business
Table 116. Astellas Pharma Latest Developments
Table 117. AstraZeneca Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. AstraZeneca Type 1 Diabetes Drugs Product Offered
Table 119. AstraZeneca Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. AstraZeneca Main Business
Table 121. AstraZeneca Latest Developments
Table 122. BHV Pharma Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. BHV Pharma Type 1 Diabetes Drugs Product Offered
Table 124. BHV Pharma Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. BHV Pharma Main Business
Table 126. BHV Pharma Latest Developments
Table 127. Biodel Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Biodel Type 1 Diabetes Drugs Product Offered
Table 129. Biodel Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Biodel Main Business
Table 131. Biodel Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Type 1 Diabetes Drugs Product Offered
Table 134. Boehringer Ingelheim Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Diamyd Therapeutics AB Basic Information, Type 1 Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Offered
Table 139. Diamyd Therapeutics AB Type 1 Diabetes Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Diamyd Therapeutics AB Main Business
Table 141. Diamyd Therapeutics AB Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Type 1 Diabetes Drugs
Figure 2. Type 1 Diabetes Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Type 1 Diabetes Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Type 1 Diabetes Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Type 1 Diabetes Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Insulins
Figure 10. Product Picture of Others
Figure 11. Global Type 1 Diabetes Drugs Sales Market Share by Type in 2021
Figure 12. Global Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Type 1 Diabetes Drugs Consumed in Drugstore
Figure 14. Global Type 1 Diabetes Drugs Market: Drugstore (2017-2022) & (K Units)
Figure 15. Type 1 Diabetes Drugs Consumed in Hospital
Figure 16. Global Type 1 Diabetes Drugs Market: Hospital (2017-2022) & (K Units)
Figure 17. Type 1 Diabetes Drugs Consumed in Others
Figure 18. Global Type 1 Diabetes Drugs Market: Others (2017-2022) & (K Units)
Figure 19. Global Type 1 Diabetes Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Type 1 Diabetes Drugs Revenue Market Share by Application in 2021
Figure 21. Type 1 Diabetes Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Type 1 Diabetes Drugs Revenue Market Share by Company in 2021
Figure 23. Global Type 1 Diabetes Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Type 1 Diabetes Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Type 1 Diabetes Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Type 1 Diabetes Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Type 1 Diabetes Drugs Sales 2017-2022 (K Units)
Figure 28. Americas Type 1 Diabetes Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Type 1 Diabetes Drugs Sales 2017-2022 (K Units)
Figure 30. APAC Type 1 Diabetes Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Type 1 Diabetes Drugs Sales 2017-2022 (K Units)
Figure 32. Europe Type 1 Diabetes Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Type 1 Diabetes Drugs Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Type 1 Diabetes Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Type 1 Diabetes Drugs Sales Market Share by Country in 2021
Figure 36. Americas Type 1 Diabetes Drugs Revenue Market Share by Country in 2021
Figure 37. United States Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Type 1 Diabetes Drugs Sales Market Share by Region in 2021
Figure 42. APAC Type 1 Diabetes Drugs Revenue Market Share by Regions in 2021
Figure 43. China Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Type 1 Diabetes Drugs Sales Market Share by Country in 2021
Figure 50. Europe Type 1 Diabetes Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Type 1 Diabetes Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Type 1 Diabetes Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Type 1 Diabetes Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Type 1 Diabetes Drugs in 2021
Figure 64. Manufacturing Process Analysis of Type 1 Diabetes Drugs
Figure 65. Industry Chain Structure of Type 1 Diabetes Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles